Low-glycemic-index, high-fiber diet for women with PCOS in rural Yunnan
Official title: Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan
Run by Shanghai First Maternity and Infant Hospital · NCT07426146 · Data updated 2026-11-12
This 6-month program will test whether a culturally adapted low-glycemic-index, high-fiber diet can improve insulin resistance, hormone levels, and menstrual regularity in women with PCOS living in remote Yunnan.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years to 40 Years |
| Sex | Women only |
| Enrollment | 56 (estimated) |
| Sponsor | Shanghai First Maternity and Infant Hospital Academic / other |
| Locations | 2 sites (Gengma County, Yunnan and 1 other locations) |
| Status | Recruiting |
| Started | August 10, 2025 |
| Main results expected | February 10, 2026 |
| Study ends | April 10, 2026 |
| Registry record updated | February 23, 2026 |
| Trial ID | NCT07426146 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with PCOS by Rotterdam criteria, BMI ≥24 kg/m², stable weight for at least 3 months, willing to keep usual activity levels, and living in the designated study area are ideal candidates.
✕Probably not a fit
Women who are pregnant or lactating, have diabetes or other endocrine disorders (e.g., thyroid disease, hyperprolactinemia, Cushing’s), or who recently used hormonal contraceptives or insulin-sensitizing/anti-obesity medications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective cohort in which women meeting Rotterdam criteria for PCOS will follow a culturally adapted low-GI, high-fiber dietary plan for six months while remaining in their usual communities. Investigators will track metabolic markers (including measures of insulin resistance), androgen levels, and menstrual cycle patterns, alongside measures of adherence and feasibility in a resource-limited setting. The intervention is tailored to local high-carbohydrate eating habits to balance nutritional goals and practicality. Outcomes will be used to generate evidence-based dietary guidance for long-term PCOS care in similar rural areas.
Why it matters
Potential benefit: If successful, the diet could improve insulin sensitivity, lower androgen levels, and help restore more regular menstrual cycles using a feasible, low-cost nutritional approach.
How similar studies have gone: Previous clinical research has shown that low-GI and high-fiber diets can improve metabolic and reproductive outcomes in PCOS, but this specific culturally adapted approach in remote Yunnan communities is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * PCOS diagnosis will follow the Rotterdam criteria (presence of two of the following three features: oligo-/anovulation, clinical/biochemical hyperandrogenism, and polycystic ovarian morphology, with exclusion of related disorders). Additional inclusion criteria comprise: body mass index (BMI) ≥24 kg/m² (Chinese obesity threshold), stable weight for at least 3 months prior to enrollment (±2 kg), willingness to maintain current physical activity levels throughout the study period, and residence within the designated study area for a minimum of 6 months. Exclusion Criteria: * pregnancy or lactation; type 1 diabetes or type 2 diabetes; thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, or other endocrine disorders affecting metabolism; use of hormonal contraceptives, insulin sensitizers, or anti-obesity medications within the past 3 months (e.g., metformin, GLP-1 receptor agonists, systemic corticosteroids, hormonal contraceptives, anti-androgens). Severe hepatic/renal/cardiovascular disease; gastrointestinal disorders incompatible with high-fiber diets; history of bariatric surgery; current participation in other dietary intervention programs; and individuals with cognitive impairment or language communication barriers who cannot comprehend the study procedures or provide informed consent. Participants will be required to maintain their habitual physical activity levels during the intervention period and must not initiate new weight-loss medications/supplements; any deviations will be documented as protocol violations
Where it's running
-
Department of Gynaecology, Gengma People's Hospital
Gengma County, Yunnan, China Recruiting -
Gengma People's Hospital
Lincang, Yunnan, China Recruiting
Study contacts
- Study coordinator: Zhiqin Chen, Doctor
- Email: ptchen1@hotmail.com
- Phone: 86+13671686734
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian drilling via vNOTES laparoscopy for PCOS patients
This study tests whether drilling the ovaries using vNOTES laparoscopy can help women with PCOS who did not respond to first-line medicines.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Lean Beef as Part of a Healthy Meal Plan for Adolescent Girls with PCOS/PMOS
This pilot study tests a lean beef–based meal plan to see if it improves blood sugar control and diet quality in adolescent girls with PCOS/PMOS.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Fecal microbiota transplantation for overweight women with PMOS undergoing embryo transfer
We are testing if oral FMT capsules are safe and can improve pregnancy outcomes for overweight/obese women with PMOS undergoing frozen embryo transfer.
-
Glp-1/FGF21 dual agonist for PCOS treatment
This study tests a GLP-1/FGF21 dual agonist to see if it helps women with PCOS by improving weight, hormones, and menstrual health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.